Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 3 Amino 3 phenylpropanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101875666A details a novel asymmetric synthesis route for high-purity Dapoxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110845369B reveals a cost-effective asymmetric Mannich route for Dapoxetine intermediates, offering superior scalability and purity for API manufacturing.